Cargando…
Matrix metalloproteinase 9 level as an indicator for restenosis following cervical and intracranial angioplasty and stenting
Cervical and intracranial angioplasty and stenting is an effective and safe method of reducing the risk of ischemic stroke, but it may be affected by in-stent restenosis. The present study investigated serum level of matrix metalloproteinase 9 as a predictor of restenosis after 40 patients underwent...
Autores principales: | Liu, Jun-peng, Wang, Yin-zhou, Li, Yong-kun, Cheng, Qiong, Zheng, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424758/ https://www.ncbi.nlm.nih.gov/pubmed/26170826 http://dx.doi.org/10.4103/1673-5374.155439 |
Ejemplares similares
-
Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases
por: Zhang, Kun, et al.
Publicado: (2021) -
Effects of a Matrix Metalloproteinase Inhibitor-Eluting Stent on In-Stent Restenosis
por: Song, Jian-bo, et al.
Publicado: (2020) -
Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis
por: Xu, Haowen, et al.
Publicado: (2020) -
Enabling Angioplasty‐Ready “Smart” Stents to Detect In‐Stent Restenosis and Occlusion
por: Chen, Xing, et al.
Publicado: (2018) -
Angioplasty and Stenting for Intracranial Stenosis
por: IZUMI, Takashi, et al.
Publicado: (2014)